Filing Details
- Accession Number:
- 0000875320-25-000039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-12 16:36:29
- Reporting Period:
- 2025-02-10
- Filing Date:
- 2025-02-12
- Accepted Time:
- 2025-02-12 16:36:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1744749 | Jonathan Biller | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp And Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-02-10 | 1,632 | $467.98 | 19,763 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2025-02-11 | 3,433 | $459.87 | 16,330 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/13/2024.
- Mr. Biller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $459.87 (range $459.83 to $460.00).
Billionaire Hedge Funds
